AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22427146 — intervention group
Group type: COMPARATOR
Intervention: Combined torsional/longitudinal ultrasound (US) mode
Number of subjects: 60
Study 19588080 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured psychosomatic diagnostics and verbal intervention (group 1, n=27)
Number of subjects: 54
Study 19588080 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2, n=27) - medical examination and consultation
Number of subjects: 54
Study 17689812 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention for primary care professionals
Number of subjects: 4060
Study 15193814 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 159
Study 15193814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study 11588130 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenretinide for 1 year
Number of subjects: 120
Study 11588130 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 120
Study 9613231 — intervention group
Group type: EXPERIMENTAL
Intervention: Blink-free saccades
Number of subjects: 16
Study 9613231 — intervention group
Group type: EXPERIMENTAL
Intervention: Blink-concurrent glissadic saccades
Number of subjects: 16
Study 8006235 — intervention group
Group type: EXPERIMENTAL
Intervention: All-Bond 2 with dentin etch
Number of subjects: 16
Study 8006235 — intervention group
Group type: EXPERIMENTAL
Intervention: All-Bond 2 without dentin etch
Number of subjects: 16
Study 8006235 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond 2
Number of subjects: 16
Study 8006235 — intervention group
Group type: EXPERIMENTAL
Intervention: Scotchbond Multi-Purpose
Number of subjects: 16
Study 8006235 — intervention group
Group type: COMPARATOR
Intervention: Enamel Bond with dentin etch (Control)
Number of subjects: 16
Study 29624413 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal crash prevention
Number of subjects: 0
Study 29624413 — intervention group
Group type: EXPERIMENTAL
Intervention: Lane maintenance
Number of subjects: 0
Study 29624413 — intervention group
Group type: EXPERIMENTAL
Intervention: Blind spot detection
Number of subjects: 0
Study 29624413 — intervention group
Group type: EXPERIMENTAL
Intervention: All 3 technologies combined
Number of subjects: 0
Study 26457558 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting bioresorbable vascular scaffold (Absorb)
Number of subjects: 2008
Study 26457558 — intervention group
Group type: COMPARATOR
Intervention: Everolimus-eluting cobalt-chromium stent (Xience)
Number of subjects: 2008
Study 24035052 — intervention group
Group type: EXPERIMENTAL
Intervention: One-hand chest compression while continuously maintaining an open airway (OCOA)
Number of subjects: 193
Study 24035052 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR (Control Group A)
Number of subjects: 193
Study 20973032 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Health Continuum-Short Form (MHC-SF)
Number of subjects: 1662
Study 18164819 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride (0.4 mg/kg)
Number of subjects: 46
Study 18164819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 16873702 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I/IGFBP-3 (0.1-0.8 mg x kg(-1) x day(-1))
Number of subjects: 15
Study 16873702 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-I/IGFBP-3
Number of subjects: 15
Study 16873702 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 12904184 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural sounds played to 29 patients using headphones during surgery (S group)
Number of subjects: 59
Study 12904184 — intervention group
Group type: COMPARATOR
Intervention: Dummy open-type headphones fitted to 30 patients (N group)
Number of subjects: 59
Study 12904184 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural sounds played to 29 patients (S group)
Number of subjects: 59
Study 12904184 — intervention group
Group type: COMPARATOR
Intervention: Dummy open-type headphones (N group)
Number of subjects: 59
Study 10678614 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose fluticasone propionate (1,000 microg x day(‐1))
Number of subjects: 24
Study 10678614 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose fluticasone propionate (100 microg x day(‐1))
Number of subjects: 24
Study 10678614 — intervention group
Group type: COMPARATOR
Intervention: Placebo (after 6 weeks of FP treatment)
Number of subjects: 24
Study 9042816 — intervention group
Group type: EXPERIMENTAL
Intervention: beta-carotene (15 mg daily)
Number of subjects: 25
Study 9042816 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study 8366412 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane barrier therapy
Number of subjects: 38
Study 8366412 — intervention group
Group type: COMPARATOR
Intervention: Control group (no collagen membrane barrier)
Number of subjects: 38
Study 3788816 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of dipyridamole
Number of subjects: 5
Study 3788816 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg of ASA
Number of subjects: 5
Study 3788816 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of dipyridamole and 25 mg of ASA together
Number of subjects: 5
Study 3788816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 30209014 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial pivot insert (MP group)
Number of subjects: 70
Study 30209014 — intervention group
Group type: COMPARATOR
Intervention: Symmetrical dish insert (SD group)
Number of subjects: 70
Study 27537372 — intervention group
Group type: EXPERIMENTAL
Intervention: Angle-modified double-lumen tube (Group M)
Number of subjects: 108
Study 27537372 — intervention group
Group type: COMPARATOR
Intervention: Non-angle-modified double-lumen tube (Group N)
Number of subjects: 108
Study 24287186 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD‐CV10 vaccine
Number of subjects: 30527
Study 24287186 — intervention group
Group type: COMPARATOR
Intervention: Control (hepatitis B or A vaccine)
Number of subjects: 30527
Study 24287186 — intervention group
Group type: EXPERIMENTAL
Intervention: PHiD‐CV10 vaccine (catch-up schedules)
Number of subjects: 30527
Study 23421308 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera toothpaste
Number of subjects: 15
Study 23421308 — intervention group
Group type: COMPARATOR
Intervention: Control toothpaste
Number of subjects: 15
Study 20207239 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1 g) and Vitamin E (400 IU) supplementation
Number of subjects: 2363
Study 20207239 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2363
Study 18279583 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 3000
Study 16102633 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for primary varicose veins with preoperative duplex scanning
Number of subjects: 293
Study 16102633 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for primary varicose veins without perforator ligation
Number of subjects: 293
Study 16102633 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery for primary varicose veins
Number of subjects: 293
Study 12450888 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed alpha‐ plus gamma‐tocotrienol supplement
Number of subjects: 67
Study 12450888 — intervention group
Group type: EXPERIMENTAL
Intervention: P25‐complex tocotrienol
Number of subjects: 67
Study 12450888 — intervention group
Group type: EXPERIMENTAL
Intervention: High gamma‐tocotrienol
Number of subjects: 67
Study 12450888 — intervention group
Group type: COMPARATOR
Intervention: Safflower oil placebo
Number of subjects: 67
Study 12450888 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall tocotrienol supplementation
Number of subjects: 67
Study 10050739 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-suppressed T1-weighted 3D-Gradient Echo (GE) images
Number of subjects: 20
Study 10050739 — intervention group
Group type: COMPARATOR
Intervention: T1-weighted SE images post-contrast (with gadolinium)
Number of subjects: 20
Study 7669470 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane concentrations (low: 0.10‐0.14 vol%, middle: 0.16‐0.20 vol%, high: 0.22‐0.26 vol%)
Number of subjects: 12
Study 7669470 — intervention group
Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane concentrations (low, middle, high)
Number of subjects: 12
Study 2392277 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol 1%
Number of subjects: 12
Study 2392277 — intervention group
Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 12
Study 2392277 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 7439253 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenazone (1.0 g X 4 for 2 days, then 0.5 g X 4 for the next 2 days)
Number of subjects: 24
Study 7439253 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenazone
Number of subjects: 24
Study 7439253 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31030626 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP self-efficacy
Number of subjects: 1884
Study 28181266 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic resistance training at 15° to 30° ankle plantarflexion at low intensity for 4 weeks
Number of subjects: 16
Study 28181266 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study 27520367 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibro-acupuncture (VA)
Number of subjects: 30
Study 27520367 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA)
Number of subjects: 30
Study 27520367 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 30
Study 24741050 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (single oral dose)
Number of subjects: 0
Study 24741050 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem (single oral dose)
Number of subjects: 0
Study 24741050 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (GABABR agonist)
Number of subjects: 0
Study 24741050 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (classical benzodiazepine)
Number of subjects: 0
Study 24741050 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22137364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR)
Number of subjects: 63
Study 22137364 — intervention group
Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 63
Study 20146343 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen section and imprint cytology
Number of subjects: 80
Study 20146343 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematoxylin‐eosin stain
Number of subjects: 80
Study 20146343 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial step sectioning (SSS) with hematoxylin‐eosin
Number of subjects: 80
Study 20146343 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen section
Number of subjects: 80
Study 20146343 — intervention group
Group type: EXPERIMENTAL
Intervention: SSS with hematoxylin‐eosin stain
Number of subjects: 80
Study 17618955 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g of a mix of inulin and oligofructose (9 subjects)
Number of subjects: 17
Study 17618955 — intervention group
Group type: COMPARATOR
Intervention: Placebo (8 subjects)
Number of subjects: 17
Study 15632028 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D gated acquisitions (3D-10)
Number of subjects: 21
Study 15632028 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D gated acquisitions (3D-5)
Number of subjects: 21
Study 15632028 — intervention group
Group type: COMPARATOR
Intervention: 2D gated acquisitions (2D-G)
Number of subjects: 21
Study 15632028 — intervention group
Group type: COMPARATOR
Intervention: 2D non-gated acquisitions (2D-NG)
Number of subjects: 21
Study 15632028 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual assessment of viability
Number of subjects: 21
Study 15632028 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction
Number of subjects: 21
Study 12358656 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam 0.1 mg.kg‐1
Number of subjects: 69
Study 12358656 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg‐1
Number of subjects: 69
Study 12358656 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 10529545 — intervention group
Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 522
Study 10529545 — intervention group
Group type: COMPARATOR
Intervention: Naratriptan 2.5 mg
Number of subjects: 522
Study 7782427 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐tryptophan‐6‐luteinizing hormone‐releasing hormone (D‐Trp‐6‐LHRH) depot (Decapeptyl 3.75) for 6 months
Number of subjects: 6
Study 7782427 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive containing 30 micrograms of ethinyl oestradiol plus 150 micrograms of desogestrel for 12 months after GnRHa therapy
Number of subjects: 6
Study 2182301 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP mask combined with regional analgesia (n = 36)
Number of subjects: 69
Study 2182301 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal intubation and mechanical ventilation with PEEP (n = 33)
Number of subjects: 69
Study 6793277 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 6
Study 6793277 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine
Number of subjects: 6
Study 31846501 — intervention group
Group type: EXPERIMENTAL
Intervention: Coach2Move strategy
Number of subjects: 400
Study 31846501 — intervention group
Group type: COMPARATOR
Intervention: Usual care physical therapy
Number of subjects: 400
Study 30565544 — intervention group
Group type: EXPERIMENTAL
Intervention: New care model mediated by care managers
Number of subjects: 248
Study 30565544 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment by primary care physician
Number of subjects: 248
Study 27405752 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral strategy for axSpA in CLBP patients
Number of subjects: 0
Study 27405752 — intervention group
Group type: COMPARATOR
Intervention: Usual care for CLBP patients
Number of subjects: 0
Study 25038977 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 30, 50 or 70 mg/day
Number of subjects: 267
Study 25038977 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 267
Study 25038977 — intervention group
Group type: COMPARATOR
Intervention: Atomoxetine (ATX)
Number of subjects: 267
Study 22338862 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq with Gum Elastic Bougie (ATQ + GEB)
Number of subjects: 141
Study 22338862 — intervention group
Group type: COMPARATOR
Intervention: Airtraq without Gum Elastic Bougie (ATQ)
Number of subjects: 141
Study 20691825 — intervention group
Group type: EXPERIMENTAL
Intervention: hs‐cTnT assay
Number of subjects: 1452
Study 20691825 — intervention group
Group type: COMPARATOR
Intervention: cTnT assay
Number of subjects: 1452
Study 20691825 — intervention group
Group type: COMPARATOR
Intervention: Negative for both assays
Number of subjects: 1452
Study 19025526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO(4)) infusion
Number of subjects: 218
Study 19025526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study 15691562 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 137
Study 15691562 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 137
Study 14500119 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS of the dominant dorsolateral prefrontal cortex
Number of subjects: 12
Study 14500119 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 12
Study 10878653 — intervention group
Group type: EXPERIMENTAL
Intervention: Lycopene (13.3 mg)
Number of subjects: 51
Study 10878653 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotene mixture (11.9 mg)
Number of subjects: 51
Study 10878653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 9368829 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate foods (PWS)
Number of subjects: 38
Study 9368829 — intervention group
Group type: COMPARATOR
Intervention: Obese controls
Number of subjects: 38
Study 1473308 — intervention group
Group type: EXPERIMENTAL
Intervention: Low bradycardia pacing rate (45.7 +/- 4 beats/min)
Number of subjects: 10
Study 1473308 — intervention group
Group type: COMPARATOR
Intervention: High bradycardia pacing rate (85.1 +/- 2 beats/min)
Number of subjects: 10
Study 4020675 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen with probenecid (500 mg every 6 hr)
Number of subjects: 20
Study 4020675 — intervention group
Group type: COMPARATOR
Intervention: Acetaminophen without probenecid
Number of subjects: 20
Study 4020675 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam with probenecid (500 mg every 6 hr)
Number of subjects: 20
Study 4020675 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam without probenecid
Number of subjects: 20
Study 30863396 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-BP180 autoantibodies measured by ELISA
Number of subjects: 100
Study 30863396 — intervention group
Group type: EXPERIMENTAL
Intervention: Sera reacting with 180-kDa proteins from human epidermal extract
Number of subjects: 100
Study 30863396 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of human recombinant full length BP180 and NC16A
Number of subjects: 100
Study 30672229 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged acupuncture combined with conventional rehabilitation
Number of subjects: 145
Study 30672229 — intervention group
Group type: COMPARATOR
Intervention: Traditional acupuncture combined with conventional rehabilitation
Number of subjects: 145
Study 30672229 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 145
Study 27346746 — intervention group
Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus chlorambucil
Number of subjects: 0
Study 27346746 — intervention group
Group type: COMPARATOR
Intervention: Chlorambucil alone
Number of subjects: 0
Study 23455717 — intervention group
Group type: EXPERIMENTAL
Intervention: FLOT (biweekly oxaliplatin plus 5‐fluorouracil continuous infusion and folinic acid plus docetaxel 50 mg/m²)
Number of subjects: 143
Study 23455717 — intervention group
Group type: COMPARATOR
Intervention: FLO (biweekly oxaliplatin plus 5‐fluorouracil continuous infusion and folinic acid)
Number of subjects: 143
Study 23327127 — intervention group
Group type: EXPERIMENTAL
Intervention: Group D (diazepam 0.2 mg/kg)
Number of subjects: 32
Study 23327127 — intervention group
Group type: EXPERIMENTAL
Intervention: Group K (ketamine 5% 30 mg/kg)
Number of subjects: 32
Study 23327127 — intervention group
Group type: EXPERIMENTAL
Intervention: Group KD (ketamine 5% 10 mg/kg + diazepam 0.2 mg/kg)
Number of subjects: 32
Study 23327127 — intervention group
Group type: COMPARATOR
Intervention: Group C (normal saline)
Number of subjects: 32
Study 20512109 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum with CPP-ACP (Group A)
Number of subjects: 88
Study 20512109 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum without CPP-ACP (Group C)
Number of subjects: 88
Study 20512109 — intervention group
Group type: COMPARATOR
Intervention: No desensitising agent (Group B)
Number of subjects: 88
Study 20512109 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 88
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates imprint exercise performed correctly (with abdominal drawing-in)
Number of subjects: 26
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Hundreds A exercise performed correctly
Number of subjects: 26
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Hundreds B exercise performed correctly
Number of subjects: 26
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg-circle exercise performed correctly
Number of subjects: 26
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Roll-up exercise performed correctly
Number of subjects: 26
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Mat imprint exercise performed correctly
Number of subjects: 26
Study 18996251 — intervention group
Group type: EXPERIMENTAL
Intervention: Reformer hundreds B exercise
Number of subjects: 26
Study 18996251 — intervention group
Group type: COMPARATOR
Intervention: Incorrect imprint exercise
Number of subjects: 26
Study 15879806 — intervention group
Group type: EXPERIMENTAL
Intervention: tamsulosin
Number of subjects: 114
Study 15879806 — intervention group
Group type: EXPERIMENTAL
Intervention: terazosin
Number of subjects: 114
Study 15879806 — intervention group
Group type: EXPERIMENTAL
Intervention: doxazosin
Number of subjects: 114
Study 15879806 — intervention group
Group type: COMPARATOR
Intervention: control group
Number of subjects: 114
Study 12641628 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose adjuvant I-131 therapy
Number of subjects: 342
Study 12641628 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 342
Study 10347109 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine and octreotide with 20% human albumin solution (50 to 100 mL daily for 20 days)
Number of subjects: 13
Study 10347109 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (2‐4 micrograms/kg/min) with the same daily amount of albumin
Number of subjects: 13
Study 8702034 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefloquine (MQ) regimen
Number of subjects: 3380
Study 8702034 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (CQ) regimen
Number of subjects: 3380
Study 1843090 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone
Number of subjects: 31
Study 6362840 — intervention group
Group type: EXPERIMENTAL
Intervention: Local excision plus cobalt irradiation
Number of subjects: 179
Study 6362840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nodal area irradiation
Number of subjects: 179
Study 6362840 — intervention group
Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 179
Study 30408271 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM) therapy
Number of subjects: 38